Corcept Therapeutics (CORT) Tops Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $110.29 -3.98%
Revenue Growth %: +56.0%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +56.0%
Financial Fact:
Loss from operations: 3.07M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q3 EPS of $0.28, $0.06 better than the analyst estimate of $0.22. Revenue for the quarter came in at $123.6 million versus the consensus estimate of $119.71 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- Circle Internet stock climbs on TD Cowen upgrade, Fed rate hike
- Lumentum shares rise on analyst upgrades, AI demand outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
